Lipella Pharmaceuticals Inc. financial data

Symbol
LIPO on Nasdaq
Industry
Pharmaceutical Preparations
Location
400 N Lexington St, Ste Ll103, Pittsburgh, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 500 % -15.9%
Debt-to-equity 24.7 % +11.8%
Return On Equity -192 % -54.9%
Return On Assets -154 % -51.7%
Operating Margin -901 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.21M shares -79.2%
Common Stock, Shares, Outstanding 1.09M shares -81.2%
Entity Public Float 9.61M USD
Common Stock, Value, Issued 109 USD -81.2%
Weighted Average Number of Shares Outstanding, Basic 1.12M shares +55.6%
Weighted Average Number of Shares Outstanding, Diluted 1.12M shares +55.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 484K USD -22.7%
Research and Development Expense 3.01M USD -1.88%
General and Administrative Expense 1.84M USD +2.49%
Operating Income (Loss) -4.36M USD +0.38%
Nonoperating Income (Expense) 95.4K USD +16.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.26M USD +0.71%
Net Income (Loss) Attributable to Parent -4.26M USD +0.71%
Earnings Per Share, Basic -0.04 USD/shares +98.3%
Earnings Per Share, Diluted -0.04 USD/shares +98.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.35M USD -43.8%
Accounts Receivable, after Allowance for Credit Loss, Current 31.1K USD -41.5%
Assets, Current 2.08M USD -22.1%
Property, Plant and Equipment, Net 10.6K USD -21.4%
Operating Lease, Right-of-Use Asset 69.6K USD -55.5%
Assets 2.16M USD -24%
Accounts Payable, Current 459K USD +51.6%
Accrued Liabilities, Current 89.8K USD +18%
Liabilities, Current 701K USD +27.8%
Operating Lease, Liability, Noncurrent 24K USD -70.4%
Liabilities 701K USD +13.2%
Retained Earnings (Accumulated Deficit) -13.9M USD -44.3%
Stockholders' Equity Attributable to Parent 1.46M USD -34.3%
Liabilities and Equity 2.16M USD -24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.39M USD -28.8%
Net Cash Provided by (Used in) Financing Activities 200K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 1.09M shares -81.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.35M USD -43.8%
Deferred Tax Assets, Valuation Allowance 2.86M USD +25.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 2.86M USD +25.4%
Operating Lease, Liability 23.8K USD +45.1%
Operating Lease, Liability, Current 70.8K USD -18.8%
Deferred Tax Assets, Operating Loss Carryforwards 1.16M USD -15.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 15.4M USD +29.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 72 USD
Operating Leases, Future Minimum Payments Due 72.8K USD -56.5%
Interest Expense 17.2K USD +233%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%